(pEF1a-PCDH1-cMyc-CMV-EGFP), PCDH9 (pEF1a-PCDH9-HA-CMV-EGFP) or CDH13
(pEF1a-CDH13-FLAG-CMV-EGFP) was tested by immunoprecipitation (IP) in HEK293T
cells transfected with the various combinations of plasmids expressing the
epitope-tagged proteins. HEK293T cells were plated at 5 × 105/well in
six-well culture plates. The next day, cells were transfected with the
expression plasmids using Lipofectamine 3000 reagent, harvested 24 h
post-transfection, lysed in cold PCDH19 lysis buffer (50 mM Tris–HCl pH 7.5, 150
mM NaCl, 0.2% Triton X-100, 2 mM EDTA, 0.01% SDS, 50 mM NaF, 0.1 mM
Na3VO4 and 1× Protease inhibitor/No EDTA (Merck),
sonicated (1 × 30% amplitude, 10 s on Sonic’s Vibra-Cell VCX) and centrifuged 15
000 r.p.m. at 4°C for 15 min. Lysis buffer with 0.4% Triton X-100 was used for
the PCDH19–CDH13 IPs. The 10% lysate was saved as input and the remainder was
subjected to IP using either EZview red anti-HA or anti-FLAG M2 agarose affinity
beads (Sigma-Aldrich). IP complexes were eluted using 1× SDS protein-loading
buffer (62.5 mM Tris–HCl, pH 6.8, 2% SDS, 10% glycerol and 5% β-mercaptoethanol [50 (link)]) at 95°C for 5 min and stored at −80°C until western blot
analysis.